Yoshihisa Ito
Overview
Explore the profile of Yoshihisa Ito including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
75
Citations
771
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kawasaki E, Jinnouchi H, Maeda Y, Okada A, Ito Y, Kawai K
J Diabetes Investig
. 2023 Jun;
14(9):1081-1091.
PMID: 37293690
Aim/introduction: This study aimed to investigate the clinical utility of 3 Screen ICA ELISA in identifying immune-mediated type 1 diabetes in Japanese subjects. Methods: We compared the positivity of 3...
2.
Naganawa H, Ito A, Saiki S, Nishi D, Takamatsu S, Ito Y, et al.
Cardiol Res Pract
. 2023 May;
2023:4594818.
PMID: 37122873
Background: Percutaneous coronary intervention using a drug-eluting stent (DES) is a common therapeutic option for acute coronary syndrome (ACS). However, stent-associated complications, such as bleeding associated with dual antiplatelet therapy,...
3.
Takehana N, Fukui T, Mori Y, Hiromura M, Terasaki M, Ohara M, et al.
J Diabetes Investig
. 2023 Apr;
14(7):856-863.
PMID: 37082800
Aims/introduction: This study aimed to compare the positivity rates of glutamic acid decarboxylase autoantibodies (GADA) and ElisaRSR™ 3 Screen ICA™ (3 Screen ICA), a newly developed assay for the simultaneous...
4.
Fukui T, Takehana N, Mori Y, Hiromura M, Terasaki M, Kushima H, et al.
Endocr J
. 2022 Jun;
69(11):1343-1349.
PMID: 35753761
To evaluate the clinical efficacy of a new enzyme-linked immunosorbent assay (ELISA) system for simultaneously detecting three islet cell autoantibodies against glutamic acid decarboxylase (GADA), insulinoma-associated antigen-2 (IA-2A), and zinc...
5.
Naganawa H, Ito A, Saiki S, Nishi D, Takamatsu S, Ito Y, et al.
Sci Rep
. 2021 Nov;
11(1):21343.
PMID: 34725431
Recently, trans-radial intervention has gained popularity as a common procedure to reduce hemorrhagic complications. However, the cuff-type hemostatic device (TR Band) previously used at our institution required 6 h to...
6.
Nagashima D, Furukawa M, Yamano Y, Yamauchi T, Okubo S, Toho M, et al.
Daru
. 2021 Aug;
29(2):321-328.
PMID: 34417987
Purpose: Mohs' paste, which is composed of zinc chloride and zinc oxide starch, is used for hemostasis of superficial malignancy in the clinical setting. We investigated the concentration of intramuscular...
7.
Ito Y, Izawa Y, Osaki T, Kamiya K, Misawa N, Fujii S, et al.
Micromachines (Basel)
. 2020 Dec;
11(12).
PMID: 33352964
Lipid-bilayer devices have been studied for on-site sensors in the fields of diagnosis, food and environmental monitoring, and safety/security inspection. In this paper, we propose a lipid-bilayer-on-a-cup device for serial...
8.
Ito Y, Osaki T, Kamiya K, Yamada T, Miki N, Takeuchi S
Small
. 2020 Nov;
16(49):e2005550.
PMID: 33191570
An artificial cell membrane is applied to study the pore formation mechanisms of bacterial pore-forming toxins for therapeutic applications. Electrical monitoring of ionic current across the membrane provides information on...
9.
Nango H, Kosuge Y, Sato M, Shibukawa Y, Aono Y, Saigusa T, et al.
Cells
. 2020 Jul;
9(7).
PMID: 32708195
Motor neuron diseases are a group of progressive neurological disorders that degenerate motor neurons. The neuroblastoma × spinal cord hybrid cell line NSC-34 is widely used as an experimental model...
10.
Kosuge Y, Nango H, Kasai H, Yanagi T, Mawatari T, Nishiyama K, et al.
Oxid Med Cell Longev
. 2020 May;
2020:6101838.
PMID: 32411331
Amyotrophic lateral sclerosis (ALS) is a devastating motor neuron disease characterized by progressive degeneration of motor neurons in the central nervous system. Prostaglandin E2 (PGE2) plays a pivotal role in...